Fighting Antimicrobial Resistance: UKRI’s Bold Approach to a Global Crisis - Health,medical news, public health,
Fighting Antimicrobial Resistance: UKRI’s Bold Approach to a Global Crisis
Antimicrobial resistance (AMR) is one of the biggest threats to global health, as pathogens become resistant to the medicines designed to treat them. This growing crisis has far-reaching effects on human, animal, and plant health, with AMR already causing major concerns for the future of healthcare.
To combat this, the UK government has set a bold 20-year vision to contain and control AMR by 2040, and UK Research and Innovation (UKRI) is at the forefront of this battle. Leading numerous initiatives and research programs, UKRI is investing heavily in interdisciplinary solutions to tackle AMR across humans, animals, plants, and the environment.
Dr. Louisa Jenkin, UKRI’s AMR Programme Lead, highlights the organization's role in driving these efforts. UKRI’s work is integral to the UK’s National Action Plan, focusing on transdisciplinary networks and collaborations across different sectors, including agriculture, medicine, diagnostics, and social sciences. The goal? To break down the silos and build a unified, global approach to tackling AMR.
UKRI has already committed £4.8m to create 8 new transdisciplinary networks, fostering collaboration between researchers and industry stakeholders. These networks aim to build long-term capacity and develop innovative solutions to combat AMR. In the upcoming phase, UKRI is set to launch larger-scale, solutions-focused research projects.
But it’s not just a UK initiative. UKRI has strong international collaborations, from European partnerships to multilateral projects in Southeast Asia, all focusing on combating AMR. One major investment is the National Biofilms Innovation Centre (NBIC), a £16m project dedicated to tackling biofilms, which play a significant role in AMR.
As the world faces an urgent need to address AMR, UKRI is committed to providing the resources, expertise, and global collaboration needed to make real progress. With a growing focus on fungal diseases, planetary health, and societal behavior, the future of AMR research looks promising.
What do you think? Can global collaboration and innovation turn the tide against antimicrobial resistance? Share your thoughts in the comments below!
0 Comments